News & Updates
Filter by Specialty:
PAGED-B score predicts HCC risk in patients entering into CHB
A novel risk score, PAGED-B, may be used to predict hepatocellular carcinoma (HCC) development at the time of transition into hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB), suggests a study.
PAGED-B score predicts HCC risk in patients entering into CHB
20 Jan 2024
HCC incidence rare in autoimmune hepatitis, tied to obesity, cirrhosis
The incidence of hepatocellular carcinoma (HCC) remains low in patients with autoimmune hepatitis (AIH) even after developing cirrhosis, according to a study. Factors such as obesity, cirrhosis, and AIH/primary sclerosing cholangitis (PSC) variant syndrome can increase the risk of HCC incidence.
HCC incidence rare in autoimmune hepatitis, tied to obesity, cirrhosis
19 Jan 2024
GLP-1RA users face no elevated risk of pancreatic cancer
Among individuals with type 2 diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) does not contribute to increased pancreatic cancer risk, according to a study.
GLP-1RA users face no elevated risk of pancreatic cancer
16 Jan 2024
Can SLN mapping replace lymphadenectomy for surgical staging of early-stage EEC?
Researchers from the KK Women’s and Children’s Hospital, Singapore found that sentinel lymph node (SLN) mapping is an acceptable and safe alternative to routine lymphadenectomy in the surgical staging of early-stage endometrioid endometrial cancer (EEC).
Can SLN mapping replace lymphadenectomy for surgical staging of early-stage EEC?
15 Jan 2024
Antivirals underutilized after curative resection of HBV- or HCV-related HCC
Antiviral therapy is associated with substantial improvements in long-term overall survival (OS) but severely underutilized after curative hepatic resection in patients with hepatitis B virus (HBV)– or hepatitis C virus (HCV)–related hepatocellular carcinoma (HCC), a real-world study involving predominantly Asian patients has shown.